The downregulation of miR-19a-3p is also known to enhance invasion, migration, and metastasis by activating TGF-β signaling in prostatic cancer [49] and hepatocellular carcinoma [50,51]. The gene discussed is TGFB1; the disease is prostate carcinoma.